Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T00:22:08.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T19:03:55.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed information about a clinical trial for a new treatment involving amivantamab and lazertinib for metastatic non-small cell lung cancer (NSCLC), including study details, eligibility criteria, and contact information for participation.
    Difference
    100%
    Check dated 2025-08-02T14:50:04.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has undergone significant deletions, including the removal of a service alert regarding planned maintenance and various details about a clinical study involving amivantamab and lazertinib for non-small cell lung cancer. This includes the study's overview, eligibility criteria, and contact information.
    Difference
    90%
    Check dated 2025-07-26T12:23:54.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-19T11:01:06.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours beginning at 9 PM EDT.
    Difference
    0.7%
    Check dated 2025-07-12T07:25:24.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.